相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A pilot study on potential plasma hypoxia markers in the radiotherapy of non-small cell lung cancer
C. Ostheimer et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2014)
Head and Neck Tumor Hypoxia Imaging by 18F-Fluoroazomycin-arabinoside (18F-FAZA)-PET
Gyorgy B. Halmos et al.
CLINICAL NUCLEAR MEDICINE (2013)
Osteopontin and splice variant expression level in human malignant glioma: Radiobiologic effects and prognosis after radiotherapy
Antje Guettler et al.
RADIOTHERAPY AND ONCOLOGY (2013)
Influence of osteopontin silencing on survival and migration of lung cancer cells
B. Polat et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2013)
Studies on the role of osteopontin-1 in endometrial cancer cell lines
J. C. Hahne et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2013)
Prognostic Significance of Plasma Osteopontin in Patients with Locoregionally Advanced Head and Neck Squamous Cell Carcinoma Treated on TROG 02.02 Phase III Trial
Annette M. Lim et al.
CLINICAL CANCER RESEARCH (2012)
Matricellular Proteins: A Sticky Affair with Cancers
Han Chung Chong et al.
JOURNAL OF ONCOLOGY (2012)
'Desperate house genes': the dramatic example of hypoxia
J. Caradec et al.
BRITISH JOURNAL OF CANCER (2010)
Clinical Significance of the Upregulated Osteopontin mRNA Expression in Human Colorectal Cancer
Wang Likui et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2010)
Effects of osteopontin inhibition on radiosensitivity of MDA-MB-231 breast cancer cells
Antje Hahnel et al.
RADIATION ONCOLOGY (2010)
Plasma Osteopontin Levels in Patients With Head and Neck Cancer Undergoing Chemoradiotherapy
Igor Snitcovsky et al.
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2009)
Plasma Osteopontin, Hypoxia, and Response to Radiotherapy in Nasopharyngeal Cancer
Edwin P. Hui et al.
CLINICAL CANCER RESEARCH (2008)
Lower osteopontin plasma levels are associated with superior outcomes in advanced non-small-cell lung cancer patients receiving platinum-based chemotherapy: SWOG study S0003
Philip C. Mack et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort study
Roy Vergis et al.
LANCET ONCOLOGY (2008)
Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer
Akeila Bellahcene et al.
NATURE REVIEWS CANCER (2008)
Expression and prognostic significance of a panel of tissue hypoxia markers in head-and-neck squamous cell carcinomas
Quynh-Thu Le et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Expression patterns of the hypoxia-related genes osteopontin, CA9, erythropoietin, VEGF and HIF-1α in human glioma in vitro and in vivo
Harun M. Said et al.
RADIOTHERAPY AND ONCOLOGY (2007)
Hypoxia in cancer: significance and impact on clinical outcome
Peter Vaupel et al.
CANCER AND METASTASIS REVIEWS (2007)
Immunohistochemical detection of osteopontin in advanced head-and-neck cancer:: Prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1α-related markers, and hemoglobin levels
Matthias Bache et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Plasma osteopontin is an independent prognostic marker for head and neck cancers
David Petrik et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
An evaluation of tumor oxygenation and gene expression in patients with early stage non-small cell lung cancers
QT Le et al.
CLINICAL CANCER RESEARCH (2006)
Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind placebo-controlled trial
J Overgaard et al.
LANCET ONCOLOGY (2005)
分享论文
